Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link
OpportunityPostedClosing

DoD Peer Reviewed Cancer, Career Development Award

Agency: AMRAA

03/21/1909/11/19

DoD Peer Reviewed Cancer, Horizon Award

Agency: AMRAA

03/21/1909/11/19

DoD Peer Reviewed Cancer, Idea Award with Special Focus

Agency: AMRAA

03/21/1909/11/19

DoD Peer Reviewed Cancer, Impact Award

Agency: AMRAA

03/21/1909/11/19

DoD Peer Reviewed Cancer, Translational Team Science Award

Agency: AMRAA

03/21/1909/11/19

U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIAIDNCINIAAANICHDNIMH

03/15/1907/26/19

U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NIAIDNCINICHD

03/15/1907/26/19

ROSES 2019: PACE Science and Applications Team

Agency: HQ

03/14/1907/15/19

NATIONAL TRIBAL AIR ASSOCIATION OPERATIONS

Agency: EPA

03/14/1905/13/19

Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/13/1910/18/20

Administrative Supplement for Research on Bioethical Issues

Agency: NIH

Institutions: NCINHGRINIANINDSFICNCATSNHLBINIAAANIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIMHNIMHDNINR

03/12/1905/13/19

Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY19 Administrative Supplement (Admin Supp Clinical Trial Optional)

Agency: NIH

Institutions: ORWHNCINEINHGRINHBLINIANIAAANIAIDNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIDANIGMSNIMHNINRNIMHDNLMNCCIH

03/01/1904/08/19

DoD Ovarian Cancer Clinical Development Award

Agency: AMRAA

03/01/1907/31/19

Early Detection of Certain Medical Conditions Related to Environmental Health Hazards

Agency: ATSDR

02/28/1904/30/19

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/27/1911/08/21

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/27/1911/08/21

Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

02/25/1905/31/19

DoD Ovarian Cancer Investigator-Initiated Research Award

Agency: AMRAA

02/22/1907/24/19

DoD Ovarian Cancer Pilot Award

Agency: AMRAA

02/22/1907/24/19

DoD Ovarian Cancer Academy - Early Career Investigator Award

Agency: AMRAA

02/22/1907/31/19

DoD Ovarian Cancer Academy Dean and Assistant Dean (Leadership) Award

Agency: AMRAA

02/22/1907/31/19

Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDORIP

02/22/1901/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Agency: NIH

Institutions: NCCIHNCINHGRINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINDSNLMORIP

02/22/1901/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

Agency: NIH

Institutions: NCCIHNCINHGRINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNIMHD

02/22/1901/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNIMHDNINDSNLMORIP

02/22/1901/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)

Agency: NIH

Institutions: NCINHLBINIANIAAANIAMSNIDCRNIEHS

02/21/1901/07/22

Advancing Cancer Immunotherapy by Mitigating Immune-related Adverse Events (irAEs) (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIAIDNIAMSNIDCRNIDDK

02/20/1904/25/19

Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients

Agency: NCCDPHP

02/20/1904/30/19

DoD Tuberous Sclerosis Complex, Clinical Translational Research Award

Agency: AMRAA

02/19/1905/09/19

The CDC Cancer Genomics Program: Translating Research into Public Health Practice

Agency: NCCDPHP

02/15/1904/15/19

Community Connect Grant Program

Agency: RUS

02/12/1904/15/19

FY2019 Research Opportunities in Accelerator Stewardship

Agency: SC

02/12/1904/23/19

Cyber-Physical Systems

Agency: NSF

02/12/1904/12/19

Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

02/08/1905/31/19

Biology of Bladder Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

Biology of Bladder Cancer (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/01/1904/01/19

NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/01/1904/01/19

Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet) (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

01/29/1903/28/19

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/24/1908/03/20

Global Noncommunicable Disease Prevention and Health Promotion

Agency: CGH

01/23/1903/25/19

DoD Breast Cancer, Breakthrough Award Levels 1 and 2

Agency: AMRAA

01/22/1903/28/19

DoD Breast Cancer, Era of Hope Scholar Award

Agency: AMRAA

01/22/1903/28/19

DoD Breast Cancer, Breakthrough Fellowship Award

Agency: AMRAA

01/22/1903/28/19

DoD Breast Cancer, Distinguished Investigator Award

Agency: AMRAA

01/22/1906/13/19

DoD Breast Cancer, Breakthrough Award Level 3

Agency: AMRAA

01/22/1906/13/19

DoD Breast Cancer, Innovator Award

Agency: AMRAA

01/22/1906/13/19

DoD Breast Cancer, Breakthrough Award Level 4

Agency: AMRAA

01/22/1906/13/19

Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

01/11/1901/03/20

The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trials Required)

Agency: NIH

Institutions: NCI

01/10/1905/22/19

The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

01/10/1905/22/19

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDANIMHDNIMHNCINCCIHORWH

01/09/1909/07/21

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDANINDSNIMHDNIMHNCINICHDORWH

01/09/1909/07/21

Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

Agency: NIH

Institutions: NIBIBNCINIANIAAANINDS

01/08/1905/07/21

Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIA

01/08/1901/07/22

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/08/1901/07/22

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIAMS

01/08/1901/07/22

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

01/08/1901/07/22

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/07/1909/27/19

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

Agency: NIH

Institutions: NICHDNEININRNIDCDNIDANINDSNHLBINCINIANIMH

12/21/1801/07/21

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

12/21/1801/07/22

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

Agency: NIH

Institutions: NINRNCINIANICHDNIDCDNIDANIMHNINDSNHLBI

12/21/1801/07/22

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINHLBINIANIAIDNIAMSNIBIBNICHDNIDCDNIDANIEHSNIMHNINDSNCCIHNINR

12/21/1801/07/22

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNCCIHNIEHS

12/20/1801/07/22

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIH

12/20/1801/07/22

NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIH

12/20/1801/07/22

NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIH

12/20/1801/07/22

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for Non-PEPFAR (President's Emergency Plan for AID Relief) Funded Countries

Agency: SUP

12/13/1809/30/20

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/12/1807/30/20

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH

12/11/1811/04/20

HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH

12/10/1802/22/21

HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH

12/10/1802/22/21

HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIBIBNIAAANIAMSNCINEINICHDNIDCRNIDDKNIDANINDSNCCIHNCATS

12/10/1802/22/21

HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH

12/10/1802/22/21

HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCATSNCCIHNCINIAAANICHDNIDANIDCRNIDDKORWH

12/10/1806/04/19

Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCIOBSSR

11/28/1803/04/21

Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNCINHLBINIAAANIDCRNINDS

11/16/1809/07/19

Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIANIAAANIAMSNICHDNIDANIDCRNIDDKNCCIHORWH

11/05/1806/04/19

Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPICs

11/05/1801/07/22

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Agency: NIH

Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH

11/02/1811/04/20

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIMHNLMNCATS

10/24/1809/05/21

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIMHNLMNCATS

10/24/1809/05/21

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIHNCATSNHLBIORIPNICHD

10/17/1802/02/21

Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH

10/05/1804/15/21

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

10/05/1803/04/21

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

10/05/1803/04/21

Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH

10/05/1812/11/20

Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]

Agency: NIH

Institutions: OBSSRNCINHLBINIANIAAANICHDNIDDKNIDANIMHNINRNIMHDNLM

10/03/1805/25/19

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/28/1807/11/21

FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (President's Emergency Plan for AIDS Relief) Funded Countries

Agency: SUP

09/28/1809/30/20

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD

09/21/1801/07/22

Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINHLBINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIHOBSSRORWH

09/19/1803/12/20

Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIH

09/19/1811/12/19

Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIH

09/19/1811/12/19

Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/12/1805/07/20

Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINCCIHNIAAANICHD

09/10/1809/07/21

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/07/1808/11/21

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1811/13/20

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIP

08/22/1809/07/21

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINCCIHODS

08/14/1809/07/21

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANINRNLMNCATSNCCIH

08/02/1803/12/20

2018 Human Exploration Research Opportunities (HERO)

Agency: JSC

08/01/1809/05/19

Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIAMSNIDAODS

07/25/1809/07/21

Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIMHD

07/25/1809/07/21

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/24/1803/08/21

Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNCCIH

07/17/1809/07/21

Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNINR

07/17/1809/07/21

Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINICHDODPOBSSR

07/12/1809/10/21

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/27/20

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/27/20

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/27/20

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/27/20

Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1809/10/20

Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1806/14/21

Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS

06/20/1809/04/21

The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNCINEI

06/14/1806/03/21

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Agency: NIH

Institutions: ODS

06/13/1811/04/19

Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINEINHLBINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIEHSFICNCCIHORIP

06/05/1804/15/20

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINIDDKNIEHSNCCIH

06/05/1804/15/20

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/24/1801/05/21

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/24/1801/05/21

Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIBIBNCI

05/16/1809/07/21

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/30/1801/09/20

Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIAIDNCINIMH

04/20/1805/07/21

Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional).

Agency: NIH

Institutions: NCINIANIDCRNINR

04/03/1805/07/21

Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional).

Agency: NIH

Institutions: NCINIANIDCRNINR

04/03/1805/07/21

Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDDKNCINCCIHODS

03/29/1809/27/19

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/29/1811/19/20

Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH

03/28/1801/07/21

Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH

03/28/1801/07/21

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD

03/28/1805/07/21

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH

03/28/1805/07/21

Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIDDKNCINICHDODS

03/27/1805/07/21

SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIAAANIDCRNIDANINR

03/06/1804/05/21

Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required)

Agency: NIH

Institutions: OppNetNCINIANIDCDNCCIHOBSSR

03/02/1804/13/19

Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/27/1810/11/19

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/23/1805/07/21

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/23/1805/07/21

Smart and Connected Health

Agency: NSF

02/21/1812/11/19

U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/21/1806/15/20

U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/21/1806/15/20

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/13/1811/19/20

Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

02/13/1811/19/20

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNINDSNIMHDNLMNCCIHNCATSORIP

02/09/1801/07/21

Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANCI

02/08/1809/07/19

Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANCI

02/08/1809/07/19

Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIB

02/07/1809/26/19

Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIB

02/07/1809/26/19

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/07/1806/13/19

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/07/1806/13/19

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1805/07/21

Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/01/1807/05/19

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/30/1804/11/19

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/30/1804/11/19

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/26/1801/25/21

Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/25/1801/25/21

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/25/1801/25/21

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )

Agency: NIH

Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP

01/25/1809/07/21

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP

01/16/1804/05/19

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDCRNIDANIGMSNIMHNINRNIMHDNCCIH

01/16/1804/05/19

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDCRNIDANIGMSNIMHNINRNIMHDNCCIH

01/16/1804/05/19

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP

01/16/1804/05/19

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

01/05/1801/07/21

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)

Agency: NIH

Institutions: NCI

01/05/1801/07/21

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDCRNIBIB

12/21/1701/07/21

International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed

Agency: NIH

Institutions: FICNCI

12/21/1703/06/20

International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required

Agency: NIH

Institutions: FICNCI

12/21/1703/06/20

Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)

Agency: NIH

Institutions: NIBIBNCINCCIH

12/15/1709/07/20

Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANINRNIMHDNCI

12/15/1705/07/20

Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANCCIHNINRNIMHDNCINHLBI

12/15/1705/07/20

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/11/1705/07/21

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/11/1705/07/21

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/06/1703/12/21

The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCI

12/06/1703/12/21

Cancer Research Education Grants Program - Curriculum or Methods Development (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Cancer Research Education Grants Program - Research Experiences (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Cancer Research Education Grants Program - Courses for Skills Development (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/30/1711/13/20

Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/30/1706/13/19

Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/30/1706/13/19

Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCINIAMSORWH

11/30/1706/07/19

Surgical Disparities Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCINIAMSORWHNINRNICHD

11/30/1706/07/19

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCINCCIHNIDCRNIDANIMHNIMHDNINDSNINR

11/29/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCINIAAANIDCRNIDDKNIDANIMHNIMHDNINDSNINR

11/29/1709/07/20

Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/29/1701/09/20

Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDA

11/28/1701/07/20

Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDA

11/28/1701/07/20

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/28/1704/11/19

Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/28/1704/11/19

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/28/1704/11/19

Population Health Interventions: Integrating Individual and Group Level Evidence (R01) - Clinical Trial Optional

Agency: NIH

Institutions: NCINIDCDNIDAOBSSR

11/22/1705/07/19

Population Health Interventions: Integrating Individual and Group Level Evidence (R21) - Clinical Trials Optional

Agency: NIH

Institutions: OBSSRNCINIDCDNIDA

11/22/1705/07/19

Population Health Interventions: Integrating Individual and Group Level Evidence (R21)- Clinical Trials Not Allowed

Agency: NIH

Institutions: OBSSRNCINIDCRNIDCD

11/21/1705/07/19

Population Health Interventions: Integrating Individual and Group Level Evidence (R01) Clinical Trials Not Allowed

Agency: NIH

Institutions: NCINIDCRNIDCDOBSSR

11/21/1705/07/19

Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNINR

11/21/1703/29/19

Methodology and Measurement in the Behavioral and Social Sciences (R21) Clinical Trials Optional

Agency: NIH

Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWHOBSSR

11/21/1709/07/19

Methodology and Measurement in the Behavioral and Social Sciences (R01) Clinical Trials Optional

Agency: NIH

Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWH

11/21/1709/07/19

NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/21/1701/07/20

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Agency: NIH

Institutions: NCINEINHGRINIANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHNHLBIORIPNINDSNIAAA

11/21/1701/07/21

NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials)

Agency: NIH

Institutions: NCI

11/20/1701/07/21

NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/20/1701/07/21

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

Agency: NIH

Institutions: NCI

11/17/1701/07/21

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

Agency: NIH

Institutions: NCI

11/17/1701/07/21

Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANIAAANCI

11/17/1709/07/19

Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/17/1709/07/19

Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/17/1709/07/19

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/15/1705/07/19

Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNIEHSODP

11/15/1705/07/20

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/08/1707/05/19

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/08/1707/16/19

Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNIANIAMSNIDDKNIDANIDCRNINDSNCCIHNIMHD

11/07/1705/07/19

Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCININRNIANIAMSNIDANIDCRNINDSNCCIHNIMHD

11/07/1705/07/19

Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

11/07/1701/07/20

Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

11/07/1701/07/20

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/06/1702/14/20

Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHD

11/06/1705/07/19

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSR

11/03/1705/07/19

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHGRINIANIAAANIAIDNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNCCIHODPOBSSRNIMHD

11/03/1705/07/19

Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIA

11/03/1701/07/20

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/03/1701/07/20

Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIA

11/03/1701/07/20

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/03/1701/07/20

NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)

Agency: NIH

Institutions: NCCIH

11/02/1702/29/20

Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCINIAAANIDANIEHS

11/01/1701/07/20

Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCINIAAANIDANIEHS

11/01/1701/07/20

Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCI

11/01/1705/07/20

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/01/1705/07/19

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDCRNIDDK

11/01/1711/05/19

Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDDKNCINCCIHODS

11/01/1709/07/19

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials)

Agency: NIH

Institutions: NCI

10/31/1701/07/21

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required)

Agency: NIH

Institutions: NCI

10/31/1701/07/21

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/30/1701/07/20

Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCINHLBINIANIDCDNIDANIMHNLMODPOBSSRNIAAA

10/20/1706/07/19

Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH

10/17/1701/07/21

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)

Agency: NIH

Institutions: NCINIDCR

10/12/1701/07/21

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed

Agency: NIH

Institutions: NCI

10/12/1710/08/20

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

10/12/1710/08/20

Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDANCCIH

10/10/1701/07/21

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

10/03/1701/07/21

Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/29/1701/07/21

Research to Improve Native American Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNIDCR

09/29/1705/14/20

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNINRNIDCR

09/29/1705/14/20

Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01)

Agency: NIH

Institutions: NIMHDNCINIAAANIDANIEHS

09/13/1712/04/19

Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R21)

Agency: NIH

Institutions: NIMHDNCINIAAANIDANIEHS

09/13/1712/04/19

Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01)

Agency: NIH

Institutions: NIMHDNCINHLBINIANINR

08/25/1711/15/19

Stimulating Access to Research in Residency (StARR) (R38)

Agency: NIH

Institutions: NHLBINCINIAIDNIA

08/23/1705/12/20

Biology of Lung, and Head and Neck Preneoplasias (R21)

Agency: NIH

Institutions: NCI

08/16/1701/07/21

Biology of Lung, and Head and Neck Preneoplasias (R01)

Agency: NIH

Institutions: NCI

08/15/1701/07/21

The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)

Agency: NIH

Institutions: NCI

08/04/1709/07/20

The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)

Agency: NIH

Institutions: NCI

08/04/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)

Agency: NIH

Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSFIC

08/01/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)

Agency: NIH

Institutions: NHGRINCINIANICHDNIEHSNINDSNIMHD

08/01/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)

Agency: NIH

Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSNINDSNIMHD

08/01/1709/07/20

Assay development and screening for discovery of chemical probes or therapeutic agents (R01)

Agency: NIH

Institutions: NCINIAIDNIDCDNIDANIMH

07/27/1709/07/20

Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)

Agency: NIH

Institutions: NCI

07/20/1709/07/20

Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)

Agency: NIH

Institutions: NCI

07/20/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R21)

Agency: NIH

Institutions: NIANCINIAAANIAMSNIDCRNIDANIMHNIMHDNINDSNINR

06/23/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R01)

Agency: NIH

Institutions: NIANCINCCIHNIAMSNIDCRNIDANIMHNIMHDNINDSNINR

06/23/1709/07/20

Integration of Individual Residential Histories into Cancer Research (R21)

Agency: NIH

Institutions: NCI

06/22/1709/07/20

Integration of Individual Residential Histories into Cancer Research (R01)

Agency: NIH

Institutions: NCI

06/22/1709/07/20

Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)

Agency: NIH

Institutions: NCI

05/16/1709/07/20

Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)

Agency: NIH

Institutions: NCI

05/16/1709/07/20

Genomic Community Resources (U24)

Agency: NIH

Institutions: NHGRINCI

05/08/1701/25/20

Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)

Agency: NIH

Institutions: NCI

04/04/1705/07/20

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)

Agency: NIH

Institutions: NCI

04/03/1705/07/20

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)

Agency: NIH

Institutions: NCINHGRINIDCR

03/30/1705/07/20

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)

Agency: NIH

Institutions: NCINHGRINIDCR

03/30/1705/07/20

Innovative Research in Cancer Nanotechnology (IRCN) (R01)

Agency: NIH

Institutions: NCI

03/30/1705/21/20

Centers for AIDS Research (P30)

Agency: NIH

Institutions: NCINHLBINIANIAIDNICHDNIDCRNIDDKNIDANIGMSNIMHNIMHDFIC

03/30/1708/17/19

Developmental Centers for AIDS Research (P30)

Agency: NIH

Institutions: NCINHLBINIANIAIDNICHDNIDCRNIDDKNIDANIGMSNIMHNIMHDFIC

03/30/1708/17/19

Mechanisms and Consequences of Sleep Disparities in the U.S. (R21)

Agency: NIH

Institutions: NIMHDNCINIANIAAANCCIHORWHNIDA

03/29/1707/11/19

Mechanisms and Consequences of Sleep Disparities in the U.S. (R01)

Agency: NIH

Institutions: NIMHDNCINHLBINIANIAAANINRNCCIHORWHNIDA

03/29/1707/11/19

Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)

Agency: NIH

Institutions: NCI

03/29/1705/07/20

Mechanisms of Alcohol-associated Cancers (R21)

Agency: NIH

Institutions: NIAAANCI

03/13/1709/07/20

Mechanisms of Alcohol-associated Cancers (R01)

Agency: NIH

Institutions: NIAAANCI

03/13/1709/07/20

Inter-organelle Communication in Cancer (R21)

Agency: NIH

Institutions: NCI

03/07/1701/15/20

Inter-organelle Communication in Cancer (R01)

Agency: NIH

Institutions: NCI

03/07/1701/15/20

Thermal Transport Processes

Agency: NSF

02/22/1708/15/19

Biophotonics

Agency: NSF

02/22/1708/15/19

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21)

Agency: NIH

Institutions: NIMHDNCINIAAA

02/02/1704/04/19

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01)

Agency: NIH

Institutions: NIMHDNCINIAAA

02/02/1704/04/19

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42)

Agency: NIH

Institutions: NIMHNCINHGRINIAMSNIDCRNIDDKNIEHSNCCIHNCATS

02/01/1701/05/20

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)

Agency: NIH

Institutions: NIMHNCINEINHGRINIAMSNIDCRNIDANIDDKNIEHSNIGMSNCCIHNCATS

02/01/1701/05/20

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)

Agency: NIH

Institutions: NCI

12/21/1601/07/20

Fertility Status as a Marker for Overall Health (R01)

Agency: NIH

Institutions: NICHDNIEHSODP

12/19/1605/07/20

Tobacco Use and HIV in Low and Middle Income Countries (R01)

Agency: NIH

Institutions: NCINIDA

12/15/1601/07/20

Tobacco Use and HIV in Low and Middle Income Countries (R21)

Agency: NIH

Institutions: NCINIDA

12/15/1601/07/20

National Cancer Institute Youth Enjoy Science Research Education Program (R25)

Agency: NIH

Institutions: NCI

11/25/1609/07/19

Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01)

Agency: NIH

Institutions: NIMHDNCINIAAANIDCRNIDANIEHS

11/01/1601/07/20

Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21)

Agency: NIH

Institutions: NIMHDNCINIAAANIDCRNIDANIEHS

11/01/1601/07/20

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01)

Agency: NIH

Institutions: NCI

10/04/1610/28/19

Kidney Precision Medicine Project - Technology Development and Validation (R43/R44)

Agency: NIH

Institutions: NIDDK

09/28/1601/05/20

Kidney Precision Medicine Project - Technology Development and Validation (R41/R42)

Agency: NIH

Institutions: NIDDK

09/28/1601/05/20

Support of Competitive Research (SCORE) Pilot Project Award (SC2)

Agency: NIH

Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDS

09/21/1609/07/19

Support of Competitive Research (SCORE) Research Advancement Award (SC1)

Agency: NIH

Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNIEHS

09/21/1609/07/19

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)

Agency: NIH

Institutions: NCINIDCR

09/07/1609/07/19

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01)

Agency: NIH

Institutions: NCINIDCR

09/07/1609/07/19

Secondary Analyses of Alcohol and Chronic Disease (R03)

Agency: NIH

Institutions: NIAAANCI

08/10/1609/07/19

Secondary Analyses of Alcohol and Chronic Disease (R01)

Agency: NIH

Institutions: NIAAANCI

08/10/1609/07/19

New Informatics Tools and Methods to Enhance US Cancer Surveillance and Research (UG3/UH3)

Agency: NIH

Institutions: NCI

06/29/1604/16/19

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03)

Agency: NIH

Institutions: NCI

06/16/1607/16/19

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21)

Agency: NIH

Institutions: NCI

06/08/1604/11/19

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01)

Agency: NIH

Institutions: NCI

06/08/1604/11/19

Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01)

Agency: NIH

Institutions: NIDCRNIAORWH

05/27/1609/07/19

Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21)

Agency: NIH

Institutions: NIDCRNIAORWH

05/27/1609/07/19

Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01)

Agency: NIH

Institutions: NCI

05/23/1606/13/19

Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21)

Agency: NIH

Institutions: NCI

05/23/1606/13/19

Serious Adverse Drug Reaction Research (R21)

Agency: NIH

Institutions: NHGRINCINIAIDNIAMSNINDS

05/19/1609/07/19

Serious Adverse Drug Reaction Research (R01)

Agency: NIH

Institutions: NHGRINCINIAIDNIAMSNINDSNIMHD

05/19/1609/07/19

Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21)

Agency: NIH

Institutions: NCI

05/16/1609/07/19

Cancer-related Behavioral Research through Integrating Existing Data (R21)

Agency: NIH

Institutions: NCI

05/11/1606/14/19

Cancer-related Behavioral Research through Integrating Existing Data (R01)

Agency: NIH

Institutions: NCI

05/11/1606/07/19

Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21)

Agency: NIH

Institutions: NCI

05/11/1604/11/19

Gene Fusions in Pediatric Sarcomas (R21)

Agency: NIH

Institutions: NCI

05/10/1605/07/19

Dissemination and Implementation Research in Health (R03)

Agency: NIH

Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSR

05/10/1605/07/19

Gene Fusions in Pediatric Sarcomas (R01)

Agency: NIH

Institutions: NCI

05/10/1605/07/19

Neural Regulation of Cancer (R21)

Agency: NIH

Institutions: NCININDS

05/09/1606/27/19

Neural Regulation of Cancer (R01)

Agency: NIH

Institutions: NCININDS

05/09/1606/27/19

Metabolic Reprogramming to Improve Immunotherapy (R21)

Agency: NIH

Institutions: NCI

05/06/1609/07/19

Metabolic Reprogramming to Improve Immunotherapy (R01)

Agency: NIH

Institutions: NCI

05/06/1609/07/19

The Role of Mobile Genetic Elements in Cancer (R21)

Agency: NIH

Institutions: NCINIA

05/05/1609/07/19

The Role of Mobile Genetic Elements in Cancer (R01)

Agency: NIH

Institutions: NCINIA

05/05/1609/07/19

Tools for Cell Line Identification (R43/R44)

Agency: NIH

Institutions: NIGMSNCINIANIAIDNIBIBNIDCRNIDANINDSNCATSORIPORWHNHGRI

04/15/1604/05/19

Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)

Agency: NIH

Institutions: NCI

04/08/1605/07/19

Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21)

Agency: NIH

Institutions: NCI

04/08/1607/16/19

Obesity Policy Evaluation Research (R01)

Agency: NIH

Institutions: NIDDKNCINIANICHDODPOBSSR

04/04/1605/07/19
  TOP